Sponsor

Apmonia Therapeutics

France Mda, 2 Rue Leon Patoux, 51100 Reims, France

About the sponsor

Apmonia Therapeutics focuses on late-stage solid tumours with limited treatment options, including advanced ovarian cancer, metastatic colorectal cancer, metastatic pancreatic cancer, and cutaneous metastatic melanoma.

Relapsed/refractory oncology
Metastatic disease
Gynaecological cancer
Gastrointestinal cancer
Melanoma

The company’s clinical activity is centred on cancers that have progressed after prior treatment, with emphasis on patients who have exhausted standard therapeutic options.

About Specializations

Apmonia Therapeutics runs clinical trials in conditions such as Neoplasm malignant, among others.

Neoplasm malignant

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Neoplasm malignant

Recruiting

A study to evaluate the safety and effectiveness of H-CYS(SS)-GLU-VAL-SER-GLN-LEU-LEU-LYS-GLY-ASP-ALA-CYS(SS)-OH in patients with advanced solid tumors who have completed other treatments.

InvestigationalNo placebo